ArticleRevista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia2026
Antimicrobial susceptibility concordance between colonising and bloodstream ESBL and carbapenemase-producing Enterobacterales in allogeneic stem cell transplant recipients: a 10-year retrospective cohort study.
Article in Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSurveillance cultures for multidrug-resistant Gram-negative bacteria are increasingly used to guide empirical therapy in allo-HSCT recipients, yet whether the antimicrobial susceptibility profile of the colonising isolate reliably predicts that of the infecting strain remains poorly characterised. The aim of the study was to evaluate antimicrobial susceptibility concordance between colonising and bloodstream extended-spectrum β-lactamase-producing Enterobacterales (ESBL-E) and carbapenem-resistant Enterobacterales (CRE) isolates in allo-HSCT patients, assess surveillance culture performance as BSI predictors, and examine whether concordance varies by timing.
methodsRetrospective cohort of 872 adult allo-HSCT recipients (2015-2024). Weekly rectal and oropharyngeal surveillance cultures were performed to detect ESBL-E and CRE. Categorical agreement between surveillance and bloodstream isolates was evaluated using the earliest and most recent surveillance cultures as reference. Factors associated with concordance were analysed using logistic regression.
resultsOf 338 colonised patients, 47 developed BSI by the same organism. Rectal cultures showed high sensitivity (CRE 74.1%, ESBL-E 69.0%) with negative predictive value≥95%; oropharyngeal cultures were independently associated with CRE BSI. Full concordance was 33.3% with the earliest isolate and 53.3% with the most recent; specific β-lactam concordance improved from 36.7% to 70.0% (p<0.01). Each additional 7 days between the most recent surveillance culture and BSI onset independently reduced the odds of β-lactam concordance by approximately 15% (aOR 0.85 [0.74-0.98], p<0.05). ESBL-E phenotype was the dominant predictor of overall concordance (aOR 6.23 [1.1-34.1], p<0.05).
conclusionsThe most recent surveillance isolate substantially outperforms the earliest as an empirical reference. The predictive value of surveillance culture antibiograms is time-dependent and mechanism-specific and should be interpreted accordingly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.